As precursors of T lymphocytes develop in the thymus and infiltrate into the bone marrow [32] and B lymphocytes or myeloid cells mainly develop in the bone marrow, it is not surprising that Sema4D expression is lower in BMMCs of T-ALL patients than in the BMMCs of B-ALL or AML patients. Here, SEMA4D is linked to acute lymphoblastic leukemia.